Effects of Zortress + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Trial Profile

Effects of Zortress + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2017

At a glance

  • Drugs Everolimus (Primary) ; Corticosteroids; Mycophenolate mofetil; Mycophenolic acid; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Aug 2017 Status changed from recruiting to withdrawn prior to enrolment as funding was withdrawn for this study by the sponsor.
    • 07 Aug 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2013)
    • 13 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top